Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Promimic AB has 1 pending office action in Biotechnology & Pharmaceuticals. The matter involves 1 distinct examiner and 1 distinct art unit, identifying a single examination assignment for the current portfolio.
ISNOR, ALEXANDRA NICOLE is the busiest examiner, with 1 pending matter, representing the complete workload shown. A focused response can address the examiner’s treatment of the biotechnology or pharmaceutical claims and the art-unit context in which those claims are being examined. The data does not indicate additional assignments requiring broader portfolio coordination.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ISNOR, ALEXANDRA NICOLE | 1 | 26.1% | +26.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18292355 | POROUS HYDROPHILIC COMPOSITES FOR USE IN PROMOTING BONE GROWTH | ISNOR, ALEXANDRA NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18292355 | POROUS HYDROPHILIC COMPOSITES FOR USE IN PROMOTING BONE GROWTH | ISNOR, ALEXANDRA NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18292355 | POROUS HYDROPHILIC COMPOSITES FOR USE IN PROMOTING BONE GROWTH | ISNOR, ALEXANDRA NICOLE | 1611 | §103§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPromimic AB has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Alexandra Nicole Isnor has the most, with 1 of Promimic AB's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.